featured
Brexpiprazole for the Treatment of Agitation in Patients With Alzheimer Dementia
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
JAMA Neurology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Brexpiprazole for the Treatment of Agitation in Alzheimer Dementia: A Randomized Clinical Trial
JAMA Neurol 2023 Nov 06;[EPub Ahead of Print], D Lee, M Slomkowski, N Hefting, D Chen, KG Larsen, E Kohegyi, M Hobart, JL Cummings, GT GrossbergFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.